View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
December 7, 2017updated 13 Dec 2017 10:19am

Neurologists: additional PML cases in MS not a major concern for Ocrevus

Roche’s Ocrevus (ocrelizumab) having additional reported cases of progressive multifocal leukoencephalopathy (PML) has not raised neurologist alarms despite analyst concern.

By GlobalData Healthcare

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology